I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| retinal cone cell | 5 studies | 23% ± 8% | |
| retinal rod cell | 5 studies | 21% ± 3% | |
| epithelial cell | 3 studies | 25% ± 12% | |
| GABAergic neuron | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal cone cell | 5 studies | 23% ± 8% | |
| retinal rod cell | 5 studies | 21% ± 3% | |
| epithelial cell | 3 studies | 25% ± 12% | |
| GABAergic neuron | 3 studies | 23% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 671.76 | 1443 / 1445 | 100% | 9.00 | 183 / 183 |
| intestine | 100% | 833.11 | 966 / 966 | 100% | 6.12 | 526 / 527 |
| prostate | 100% | 868.62 | 245 / 245 | 100% | 4.40 | 501 / 502 |
| lung | 100% | 1311.87 | 578 / 578 | 99% | 6.41 | 1145 / 1155 |
| stomach | 100% | 823.30 | 358 / 359 | 99% | 7.02 | 284 / 286 |
| pancreas | 100% | 548.78 | 328 / 328 | 99% | 4.66 | 176 / 178 |
| bladder | 100% | 582.57 | 21 / 21 | 99% | 4.98 | 498 / 504 |
| breast | 100% | 504.89 | 458 / 459 | 97% | 3.84 | 1087 / 1118 |
| uterus | 100% | 501.92 | 170 / 170 | 97% | 5.37 | 444 / 459 |
| thymus | 100% | 751.32 | 653 / 653 | 97% | 3.27 | 584 / 605 |
| skin | 98% | 449.89 | 1770 / 1809 | 94% | 3.97 | 442 / 472 |
| kidney | 100% | 553.67 | 89 / 89 | 91% | 2.51 | 823 / 901 |
| ovary | 88% | 255.60 | 159 / 180 | 98% | 4.82 | 420 / 430 |
| brain | 87% | 378.74 | 2302 / 2642 | 97% | 2.76 | 687 / 705 |
| adrenal gland | 99% | 393.88 | 256 / 258 | 81% | 2.40 | 187 / 230 |
| liver | 99% | 369.08 | 224 / 226 | 79% | 2.35 | 322 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.91 | 29 / 29 |
| peripheral blood | 100% | 3352.44 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1662.79 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 5.24 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.05 | 1 / 1 |
| adipose | 100% | 485.73 | 1200 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 595.33 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 91% | 338.76 | 733 / 803 | 0% | 0 | 0 / 0 |
| heart | 85% | 238.98 | 733 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 45% | 0.87 | 36 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008150 | Biological process | biological_process |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARID3B |
| Protein name | AT-rich interactive domain-containing protein 3 (ARID domain-containing protein) AT-rich interactive domain-containing protein 3B (ARID domain-containing protein 3B) (Bright and dead ringer protein) (Bright-like protein) |
| Synonyms | BDP DRIL2 |
| Description | FUNCTION: Transcription factor which may be involved in neuroblastoma growth and malignant transformation. Favors nuclear targeting of ARID3A. . FUNCTION: Transcription factor. . |
| Accessions | ENST00000346246.10 [Q8IVW6-4] H3BQ92 ENST00000622429.1 [Q8IVW6-1] ENST00000566147.1 Q8IVW6 |
